209 results on '"Paldino, Alessia"'
Search Results
2. Pregnancy in women with dilated cardiomyopathy genetic variants
3. Embarazo en mujeres portadoras de variantes genéticas de miocardiopatía dilatada
4. Prevalence, Penetrance, and Phenotypic Manifestation of Cardiomyopathy-Associated Genetic Variants in the General Population: Insights from a Mayo Clinic Biobank Study
5. Impact of DCM-Causing Genetic Background on Long-Term Response to Cardiac Resynchronization Therapy
6. Cardiac Magnetic Resonance Feature-Tracking Identifies Preclinical Abnormalities in Hypertrophic Cardiomyopathy Sarcomere Gene Mutation Carriers
7. SARS-CoV-2 infection induces DNA damage, through CHK1 degradation and impaired 53BP1 recruitment, and cellular senescence
8. Prognostic value of echocardiographic evaluation of cardiac mechanics in patients with aortic stenosis and preserved left ventricular ejection fraction
9. Abstract 15195: Utility of a Polygenic Risk Score for Dilated Cardiomyopathy in the General Population
10. Abstract 14249: Sex and Gene Based Differences in Age Related Penetrance of Dilated and Arrhythmogenic Cardiomyopathy
11. Dilated Cardiomyopathy
12. Mechanisms of myocardial reverse remodelling and its clinical significance: A scientific statement of the ESC Working Group on Myocardial Function
13. Reply to the letter regarding the article ‘Subclinical systolic dysfunction in genotype‐positive phenotype‐negative relatives of dilated cardiomyopathy patients: A systematic review and meta‐analysis’
14. Prevalence and Evolution of Right Ventricular Dysfunction Among Different Genetic Backgrounds in Dilated Cardiomyopathy
15. SARS-CoV-2, myocardial injury and inflammation: insights from a large clinical and autopsy study
16. High prevalence of subtle systolic and diastolic dysfunction in genotype-positive phenotype-negative relatives of dilated cardiomyopathy patients
17. Subclinical systolic dysfunction in genotype‐positive phenotype‐negative relatives of dilated cardiomyopathy patients: A systematic review and meta‐analysis
18. Apoptosis, a useful marker in the management of hot‐phase cardiomyopathy?
19. Mechanisms of myocardial reverse remodelling and its clinical significance: A scientific statement of the ESC Working Group on Myocardial Function
20. Current Management and Treatment
21. ICD replacement in patients with intermediate left ventricular dysfunction under optimal medical treatment
22. Left bundle branch block in dilated cardiomyopathy with intermediate left ventricular dysfunction: Clinical phenotyping and outcome correlates
23. Myocarditis: Which Role for Genetics?
24. Generation of human induced pluripotent stem cell line EURACi015-A from a patient affected by dilated cardiomyopathy carrying the Lamin A/C p.Glu161Lys mutation
25. Role of arrhythmic phenotype in prognostic stratification and management of dilated cardiomyopathy.
26. Echocardiographic evaluation of centenarians in Trieste
27. P185: Genome and exome sequencing to define cardiac phenotypes in diagnostic odyssey cases
28. Correction to: SARS‑CoV‑2, myocardial injury and inflammation: insights from a large clinical and autopsy study
29. Contributors
30. Noncoding RNAs in Cardiovascular Disease
31. Heart Transplantation in Kearns-Sayre Syndrome
32. Arrhythmic risk stratification in patients with dilated cardiomyopathy and intermediate left ventricular dysfunction
33. New perspectives in diagnosis and risk stratification of non-ischaemic dilated cardiomyopathy
34. Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy
35. Sport and Exercise in Genotype positive (+) Phenotype negative (-) Individuals. Current Dilemmas and Future Perspectives
36. CARDIAC MAGNETIC RESONANCE PHENOTYPE AND GENOTYPE IN LEFT-SIDED CARDIOMYOPATHIES: CHARACTERIZATION AND CLINICAL OUTCOMES
37. Whole‐exome sequencing: Clinical characterization of pediatric and adult Italian patients affected by different forms of hereditary cardiovascular diseases
38. Effects of oral immunonutrition on histological changes of inflammatory infiltration of the tumor microenvironment among patients with a new diagnosis of gastric cancer
39. 915 PHENOTYPIC EXPRESSION AND OUTCOMES OF CARDIOMYOPATHY CAUSED BY TITIN TRUNCATING VARIANTS: TRANSLATIONAL INSIGHTS
40. 398 CARDIAC MAGNETIC RESONANCE PHENOTYPE AND GENOTYPE IN LEFT-SIDED CARDIOMYOPATHIES: CHARACTERIZATION AND CLINICAL OUTCOMES
41. 1117 FAMILY SCREENING IN DILATED CARDIOMYOPATHY: CLINICAL CHARACTERIZATION AND FOLLOW UP OF RELATIVES
42. 207 RE-DEFINING ARRHYTHMOGENIC CARDIOMYOPATHY: CHARACTERIZATION AND LONG-TERM PROGNOSTIC IMPLICATIONS
43. Prognostic value of echocardiographic evaluation of cardiac mechanics in patients with aortic stenosis and preserved left ventricular ejection fraction
44. Cardiology of the future: xenotransplantation with porcine heart
45. Prognostic Prediction of Genotype vs Phenotype in Genetic Cardiomyopathies
46. Heart failure with supra‐normal left ventricular ejection fraction: distinct polygenic bases of an unrecognized phenotype
47. Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated Cardiomyopathy
48. Sport and exercise in genotype positive (+) phenotype negative (−) individuals: current dilemmas and future perspectives.
49. Global longitudinal strain by CMR improves prognostic stratification in acute myocarditis presenting with normal LVEF
50. Association of Titin Variations With Late-Onset Dilated Cardiomyopathy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.